国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2010年
14期
1705-1707
,共3页
糖尿病%超声乳化%白内障%人工晶体
糖尿病%超聲乳化%白內障%人工晶體
당뇨병%초성유화%백내장%인공정체
Diabetes tnellitus%Phacoemulsification%Cataract%Intraocular lens
目的 探讨糖尿病(DM)患者行白内障超声乳化摘出联合人工晶体植入术的临床效果.方法 对76例(82眼)糖尿病白内障患者与76例(82眼)非糖尿病白内障患者行白内障超声乳化摘除联合人工晶体植入术后的视力及并发症进行对照研究.结果 两组术后视力、并发症较差异无显著性(P>0.05),最终视力在0.6以上:糖尿病组眼占68.29%,非糖尿病组眼占75.61%.糖尿病白内障患者中,术后出现并发症角膜水肿21眼,纤维蛋白渗出7眼,前房积血3眼,后角膜色素沉着26眼,虹膜后粘连3眼,后囊混浊27眼,均高于无糖尿病患者(P<0.05).结论 糖尿病白内障患者只要术前眼部无严重并发症,行超声乳化摘除联合人工晶体植入术,就可明显改善视力,且手术安全可靠.
目的 探討糖尿病(DM)患者行白內障超聲乳化摘齣聯閤人工晶體植入術的臨床效果.方法 對76例(82眼)糖尿病白內障患者與76例(82眼)非糖尿病白內障患者行白內障超聲乳化摘除聯閤人工晶體植入術後的視力及併髮癥進行對照研究.結果 兩組術後視力、併髮癥較差異無顯著性(P>0.05),最終視力在0.6以上:糖尿病組眼佔68.29%,非糖尿病組眼佔75.61%.糖尿病白內障患者中,術後齣現併髮癥角膜水腫21眼,纖維蛋白滲齣7眼,前房積血3眼,後角膜色素沉著26眼,虹膜後粘連3眼,後囊混濁27眼,均高于無糖尿病患者(P<0.05).結論 糖尿病白內障患者隻要術前眼部無嚴重併髮癥,行超聲乳化摘除聯閤人工晶體植入術,就可明顯改善視力,且手術安全可靠.
목적 탐토당뇨병(DM)환자행백내장초성유화적출연합인공정체식입술적림상효과.방법 대76례(82안)당뇨병백내장환자여76례(82안)비당뇨병백내장환자행백내장초성유화적제연합인공정체식입술후적시력급병발증진행대조연구.결과 량조술후시력、병발증교차이무현저성(P>0.05),최종시력재0.6이상:당뇨병조안점68.29%,비당뇨병조안점75.61%.당뇨병백내장환자중,술후출현병발증각막수종21안,섬유단백삼출7안,전방적혈3안,후각막색소침착26안,홍막후점련3안,후낭혼탁27안,균고우무당뇨병환자(P<0.05).결론 당뇨병백내장환자지요술전안부무엄중병발증,행초성유화적제연합인공정체식입술,취가명현개선시력,차수술안전가고.
Objective To explore the efficacy of phacoemulsification combined with intraocular lens implantation for cataract in patients with diabetes mellitus (DM).Methods 76 patients with diabetic cataract (82 eyes) and 76 non-diabetic patients with cataract (82 eyes) underwent phacoemulsification combined with intraocular lens implantation.The visual acuity and complications of the procedure were noted.Results There were no significant differences between the two groups in postoperative visual acuity and complications (P>0.05).The final visual acuity of 0.6 or above was 68.29% in the diabetes group and was 75.61% in the non-diabetes group.Conclusions Phacoemulsification combined with intraocular lens implantation is safe and reliable in improving visual acuity,only if the patients with diabetic cataract have no severe postoperative complications of eyes.